Tumor-expressed PD-L1 is a viable immune-escape mechanism in the absence of treatment, across a range of vascularization, but treatment with anti-PD-L1 selects for the two acid-inactivation metaphenotypes (Self-Acidify and Mooch Acid). Here, CD274 is linked to neoplasm.